Cardio Diagnostics Holdings Inc. CDIO 深 沪
已收盘 02-13 16:00:00 美东时间
1.27
-0.020
-1.55%
华盛通- 最 高1.35
- 今 开1.26
- 成交量 4.46万股
- 最 低 1.2305
- 昨 收 1.29
- 总市值 231.91万
- 52周最高 17.388
- 市盈率 静 --
- 换手率 2.44%
- 52周最低 0.97
- 委 比 -58.50%
- 总股本 182.61万
- 历史最高 307.50
- 量 比 0.34
- 振 幅 9.26%
- 历史最低 0.97
- 每 手 1
- 风险率 4.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cardio Diagnostics Bets On India To Scale AI Heart Diagnostics
Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs partner to bring PrecisionCHD test to India, aiming to address high heart disease rates.
01-09 01:19
Market-Moving News for January 7th
GLUE: 42% | Monte Rosa Therapeutics shares are trading higher after the company announced it will present interim clinical results from the ongoing Phase 1 study of NEK7-directed MGD MRT-8102. VTYX: 74% |
01-07 20:17
Cardio Diagnostics' PrecisionCHD Test To Detect Hidden Forms Of Heart Disease INOCA And MINOCA, To Be Presented At AHA Sessions
Ischemia with No Obstructive Coronary Arteries (INOCA) and Myocardial Infarction with No Obstructive Coronary Arteries (MINOCA) are two underdiagnosed, potentially fatal forms of heart disease that standard diagnostic testing routinely fails to detect
2025-11-05 21:37
Cardio Diagnostics Enters Partnerships With 15 New U.S. Provider Organizations, Expanding Adoption Of Its AI-driven Blood Tests, Epi+Gen CHD And PrecisionCHD Which Aim To Improve Prevention, Detection, And Management Of Coronary Heart Disease Across Diverse Clinical Settings
Growing Adoption of AI-Driven Precision Cardiovascular Medicine Tests Spans Concierge, Functional Medicine, and Primary Care PracticesCardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven Precision Cardiovascular
2025-10-21 20:38
Cardio Diagnostics Holdings Inc. Announces Date for Upcoming Annual Stockholders Meeting
Cardio Diagnostics Holdings Inc. has announced its annual meeting of stockholders scheduled for October 15, 2025. The meeting will be held virtually. During the meeting, stockholders will be asked to ...
2025-09-04 20:01
Cardio Diagnostics Hldgs Q2 EPS $(0.97) Beats $(1.80) Estimate, Sales $7.475K Miss $75.000K Estimate
Cardio Diagnostics Hldgs (NASDAQ:CDIO) reported quarterly losses of $(0.97) per share which beat the analyst consensus estimate of $(1.80) by 46.11 percent. This is a 46.11 percent increase over losses of $(1.80) per
2025-08-15 04:41
Cardio Diagnostics Secures Preliminary Medicare Payment Rates For Epi+Gen CHD And PrecisionCHD, Marking Key Reimbursement Milestone
Obtaining the payment rates marks a key milestone in gaining broad access to Medicare reimbursement.Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-powered precision cardiovascular medicine company, today
2025-07-22 20:36
Cardio Diagnostics Holdings Inc. Announces New Clinical Study Using PrecisionCHD™ to Test LODOCO® for Inflammation-Driven Coronary Heart Disease
Cardio Diagnostics Holdings Inc. has announced a new clinical study in collaboration with AGEPHA Pharma to investigate a precision-guided approach to managing inflammation-driven coronary heart diseas...
2025-07-08 20:31
Cardio Diagnostics Holdings Inc. Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology
Cardio Diagnostics Holdings Inc. announced that the Japan Patent Office has issued a patent for its AI-driven cardiovascular disease detection technology. The patent, titled "Compositions and Methods ...
2025-06-10 20:35
Cardio Diagnostics regains Nasdaq compliance following reverse stock split
Cardio Diagnostics Holdings (NASDAQ:CDIO) received a Nasdaq notice confirming compliance with the $1 minimum bid price requirement. The compliance follows a 1-for-30 reverse stock split effective May ...
2025-05-29 21:17
